Minimum Effective dose of Dexamethasone in Combination with Midazolam as Prophylaxis against Postoperative Nausea and Vomiting after Laparoscopic Cholecystectomy
- PMID: 29962605
- PMCID: PMC6020576
- DOI: 10.4103/aer.AER_19_18
Minimum Effective dose of Dexamethasone in Combination with Midazolam as Prophylaxis against Postoperative Nausea and Vomiting after Laparoscopic Cholecystectomy
Abstract
Background: Postoperative nausea and vomiting (PONV) affects 20% and 30% of patients. As many as 60%-80% patients at high risk may be affected. Dexamethasone (D) and midazolam (M) are well studied as antiemetic. Use of D can be associated with certain undesirable side effects so minimum dose is preferred. M is a routinely used premedicant. Hence, this study was designed with both D and M in high risk patients for PONV to find minimum effective dose of D.
Aims: To determine the minimum dose of D that combined with M would provide effective prophylaxis of PONV after laparoscopic cholecystectomy (LC) in patients at high risk for PONV.
Setting and design: This is a prospective, randomized double-blind trial.
Materials and methods: One hundred and fifty-five patients scheduled for elective LC were randomized to 5 groups of 31 each. Group C was given normal saline, and the rest were administered D 1 mg (group MD1), 2 mg (group MD2), 4 mg (group MD4), or 8 mg (group MD8) in combination with 0.04 mg/kg M at induction. The incidence of nausea, vomiting, severity of nausea, and the use of rescue antiemetic and postoperative pain was analyzed.
Statistical analysis: Chi-square test was used to compare incidence of study variables. Independent Student's t-test was used for continuous variables. Demographic data were compared using ANOVA. P < 0.05 was considered statistically significant.
Results: The incidence of nausea was significantly lower in group MD4 (29%) and MD8 (6%) compared to placebo group (71%) (P < 0.001) and of vomiting was significantly lower in groups of MD2 (58%), MD4 (48%), and MD8 (6%) compared with placebo (90%) (P < 0.001) at 24 h. There was significant reduction in nausea, pain severity, and incidence of use of rescue antiemetic in MD4 and MD8 groups with no discernable side effects of the drugs.
Conclusion: We conclude that 4 mg D with M and 2 mg D with M is effective for prevention of nausea and vomiting, respectively, in patients at high risk for PONV undergoing LC.
Keywords: Dexamethasone; laparoscopic surgery; midazolam; postoperative nausea and vomiting.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
Antiemetic prophylaxis against postoperative nausea and vomiting with ondansetron-dexamethasone combination compared to ondansetron or dexamethasone alone for patients undergoing laparoscopic cholecystectomy.Kathmandu Univ Med J (KUMJ). 2008 Jul-Sep;6(23):319-28. doi: 10.3126/kumj.v6i3.1706. Kathmandu Univ Med J (KUMJ). 2008. PMID: 20071813 Clinical Trial.
-
Small-dose dexamethasone reduces nausea and vomiting after laparoscopic cholecystectomy: a comparison of tropisetron with saline.Anesth Analg. 2002 Jul;95(1):229-32, table of contents. doi: 10.1097/00000539-200207000-00042. Anesth Analg. 2002. PMID: 12088975 Clinical Trial.
-
Metoclopramide, versus its combination with dexamethasone in the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: a double-blind randomized controlled trial.J Med Assoc Thai. 2015 Mar;98(3):265-72. J Med Assoc Thai. 2015. PMID: 25920297 Clinical Trial.
-
The utility of antiemetics in the prevention and treatment of postoperative nausea and vomiting in patients scheduled for laparoscopic cholecystectomy.Curr Pharm Des. 2005;11(24):3173-83. doi: 10.2174/1381612054864911. Curr Pharm Des. 2005. PMID: 16178752 Review.
-
The effect of transdermal scopolamine for the prevention of postoperative nausea and vomiting.Front Pharmacol. 2014 Apr 9;5:55. doi: 10.3389/fphar.2014.00055. eCollection 2014. Front Pharmacol. 2014. PMID: 24782768 Free PMC article. Review.
Cited by
-
Management strategies for the treatment and prevention of postoperative/postdischarge nausea and vomiting: an updated review.F1000Res. 2020 Aug 13;9:F1000 Faculty Rev-983. doi: 10.12688/f1000research.21832.1. eCollection 2020. F1000Res. 2020. PMID: 32913634 Free PMC article. Review.
-
Clinical practice guidelines for enhanced recovery after colon and rectal surgery from the American Society of Colon and Rectal Surgeons and the Society of American Gastrointestinal and Endoscopic Surgeons.Surg Endosc. 2023 Jan;37(1):5-30. doi: 10.1007/s00464-022-09758-x. Epub 2022 Dec 14. Surg Endosc. 2023. PMID: 36515747 Free PMC article.
-
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2. Cochrane Database Syst Rev. 2020. PMID: 33075160 Free PMC article.
-
Beyond the Operating Room: A Narrative Review of Enhanced Recovery Strategies in Colorectal Surgery.Cureus. 2024 Dec 21;16(12):e76123. doi: 10.7759/cureus.76123. eCollection 2024 Dec. Cureus. 2024. PMID: 39840197 Free PMC article. Review.
References
-
- Kovac AL. Prevention and treatment of postoperative nausea and vomiting. Drugs. 2000;59:213–43. - PubMed
-
- Watcha MF, White PF. Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology. 1992;77:162–84. - PubMed
-
- Apfel CC, Läärä E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting: Conclusions from cross-validations between two centers. Anesthesiology. 1999;91:693–700. - PubMed
-
- Gan TJ. Risk factors for postoperative nausea and vomiting. Anesth Analg. 2006;102:1884–98. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials